Literature DB >> 7981066

P-glycoprotein and glutathione S-transferase pi in childhood acute lymphoblastic leukaemia.

A Sauerbrey1, F Zintl, M Volm.   

Abstract

Blast cells obtained from 104 children with untreated acute lymphoblastic leukaemia were analysed for the expression of P-glycoprotein (P-170) and glutathione S-transfer pi (GST-pi) using immunohistochemistry. Expression of P-170 was detected in 36 of 104 patients (35%) and increased GST-pi was seen in 52 patients (50%). Coexpression of both resistance proteins was observed in 22 leukaemias (21%), whereas no evidence of the resistance markers was found in 38 cases (37%). In patients with P-170-positive leukaemic cells, a significantly lower probability of remaining in first continuous complete remission (CCR) was observed when compared with patients with P-170-negative tumours (P < 0.05). However, only a trend for a more frequent expression of P-170 was found in the leukaemic cells of patients who experienced relapses (P = 0.099). Overexpression of GST-pi was correlated with a higher relapse rate (P = 0.001) and a lower probability of remaining in first CCR (P = 0.01). Expression of P-170 and GST-pi was independent of sex, FAB type, immunological subtype and initial blast cell count. The multivariate analysis indicated that only the expression of P-170 is an unfavourable prognostic factor for children with acute lymphoblastic leukaemia in addition to the prognostic clinical factors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7981066      PMCID: PMC2033687          DOI: 10.1038/bjc.1994.462

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  35 in total

1.  Immunocytochemical detection of a resistance-associated glycoprotein in tissue culture cells, ascites tumors and human tumor xenografts by Mab 265/F4.

Authors:  M Volm; M Bak; T Efferth; B Lathan; J Mattern
Journal:  Anticancer Res       Date:  1988 Jul-Aug       Impact factor: 2.480

Review 2.  The biochemistry of P-glycoprotein-mediated multidrug resistance.

Authors:  J A Endicott; V Ling
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

3.  Failure to detect the P-glycoprotein multidrug resistant phenotype in cases of resistant childhood acute lymphocytic leukaemia.

Authors:  P Ubezio; M Limonta; M D'Incalci; G Damia; G Masera; G Giudici; J S Wolverton; W T Beck
Journal:  Eur J Cancer Clin Oncol       Date:  1989-12

4.  Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors.

Authors:  J A Moscow; C R Fairchild; M J Madden; D T Ransom; H S Wieand; E E O'Brien; D G Poplack; J Cossman; C E Myers; K H Cowan
Journal:  Cancer Res       Date:  1989-03-15       Impact factor: 12.701

5.  Multidrug resistance in haemopoietic cell lines, myelodysplastic syndromes and acute myeloblastic leukaemia.

Authors:  J Holmes; A Jacobs; G Carter; A Janowska-Wieczorek; R A Padua
Journal:  Br J Haematol       Date:  1989-05       Impact factor: 6.998

6.  Increased P-glycoprotein expression and multidrug-resistant gene (mdr1) amplification are infrequently found in fresh acute leukemia cells. Sequential analysis of 15 cases at initial presentation and relapsed stage.

Authors:  Y Ito; M Tanimoto; T Kumazawa; M Okumura; Y Morishima; R Ohno; H Saito
Journal:  Cancer       Date:  1989-04-15       Impact factor: 6.860

7.  Expression of the mdr-1/P-170 gene in patients with acute lymphoblastic leukemia.

Authors:  M L Rothenberg; L A Mickley; D E Cole; F M Balis; T Tsuruo; D G Poplack; A T Fojo
Journal:  Blood       Date:  1989-09       Impact factor: 22.113

8.  Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

9.  Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood.

Authors:  H S Chan; P S Thorner; G Haddad; V Ling
Journal:  J Clin Oncol       Date:  1990-04       Impact factor: 44.544

10.  Observations on the transcriptional activity of the glutathione S-transferase pi gene in human haematological malignancies and in the peripheral leucocytes of cancer patients under chemotherapy.

Authors:  S McQuaid; S McCann; P Daly; E Lawlor; P Humphries
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

View more
  4 in total

1.  Morphoproteomic confirmation of an activated nuclear factor-кBp65 pathway in follicular thyroid carcinoma.

Authors:  Jing Liu; Robert E Brown
Journal:  Int J Clin Exp Pathol       Date:  2012-03-25

2.  Expression of metallothionein in initial and relapsed childhood acute lymphoblastic leukemia.

Authors:  A Sauerbrey; F Zintl; M Volm
Journal:  Ann Hematol       Date:  1994-09       Impact factor: 3.673

3.  Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells.

Authors:  Shanshan Pei; Mohammad Minhajuddin; Kevin P Callahan; Marlene Balys; John M Ashton; Sarah J Neering; Eleni D Lagadinou; Cheryl Corbett; Haobin Ye; Jane L Liesveld; Kristen M O'Dwyer; Zheng Li; Lei Shi; Patricia Greninger; Jeffrey Settleman; Cyril Benes; Fred K Hagen; Joshua Munger; Peter A Crooks; Michael W Becker; Craig T Jordan
Journal:  J Biol Chem       Date:  2013-10-02       Impact factor: 5.157

4.  Glutathione s-transferases in pediatric cancer.

Authors:  Wen Luo; Michelle Kinsey; Joshua D Schiffman; Stephen L Lessnick
Journal:  Front Oncol       Date:  2011-10-24       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.